New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
10:25 EDTEWEdwards Lifesciences rises sharply following court action, upgrades
The stock is up 13.6% to $82.97 following a U.S. District Court preliminary injunction that limits sales of Medtronic's (MDT) CoreValve system in the United States. JPMorgan and CRT Capital upgraded the name to Neutral and Buy, respectively. Wells Fargo upped its price target to $90 to $91. At current price the next major resistance level is at $86.11, the 52-week high. Support is at $81.93, the opening price of the day.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2015
16:30 EDTEWEdwards Lifesciences sees Q3 EPS 92c-$1.00, consensus 98c
Sees Q3 revenue $580M-$620M, consensus $587.06M.
16:28 EDTEWEdwards Lifesciences raises FY15 EPS view to $4.30-44.40, consensus $4.28
Backs FY15 revenue view $2.3B-$2.5B, consensus $2.41B
16:26 EDTEWEdwards Lifesciences reports Q2 EPS $1.13 , consensus $1.05
Subscribe for More Information
15:21 EDTEWNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use